Osteoarthritis
Drug research and approvals for osteoarthritis: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 604 studies of osteoarthritis are recruiting on ClinicalTrials.gov, and Health Canada has authorized 48 drug trials for it since 2013.
- Recruiting worldwide: 604
- Trials authorized in Canada: 48
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 604 recruiting on ClinicalTrials.gov ↗- Undenatured Type II Collagen for Knee Osteoarthritis PainNCT07870967 · Not applicable · Universidad Católica San Antonio de Murcia · starts Mar 1, 2027
- IMAGES: Identifying Metabolic Imaging Association With Genicular Artery Embolization SuccessNCT07494838 · Not applicable · Lucas R. Cusumano, MD · starts Dec 30, 2026
- Study NRPT Feasibility in Knee OsteoarthritisNCT07917403 · Not applicable · University of California, San Diego · starts Dec 1, 2026
- Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of Trapeziometacarpal…NCT07435571 · Phase 2 · TBF Genie Tissulaire · starts Nov 1, 2026
- SVF Cellular Composition, Secretome, and Responses in Knee OsteoarthritisNCT07898501 · Not reported · Yonsei University · starts Nov 1, 2026
- Lubricin-inspired Osteoarthritis Treatment: a Unique SolutionNCT07611708 · Not applicable · Pleryon Therapeutics (Hangzhou) Limited · starts Nov 1, 2026
- A Study to Learn About Berobenatide Given Once Weekly in Adults With Knee Osteoarthritis and Overweight or Obesity With…NCT07915609 · Phase 3 · Pfizer · starts Oct 26, 2026
- A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA…NCT07919678 · Phase 3 · Pfizer · starts Oct 26, 2026
- Tornier Perform™ Reversed Monopost StudyNCT07764614 · Not reported · Stryker Trauma and Extremities · starts Oct 22, 2026
- Daily Knee Sleeve Use Versus No Use in Older Adults With Chronic Knee PainNCT07674901 · Not applicable · Margaret L Gourlay, MD, MPH · starts Oct 21, 2026
Trials Authorized in Canada
The 10 newest of 48; search them all in Canada trials| Sep 14, 2026 | A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of once-weekly berobenatide in adults with knee osteoarthritis…BEROBENATIDE (PF-08653944) | Pfizer | Pending |
| Aug 20, 2026 | A phase 3, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of once-monthly berobenatide in adults with knee osteoarthritis…BEROBENATIDE (PF-08653944, MET097) | Pfizer | Pending |
| Feb 25, 2026 | Master protocol: a master protocol for phase 3 randomized, double-blind, placebo-controlled studies to investigate the efficacy and safety of once weekly…ELORALINTIDE (LY3841136) | Eli Lilly | Ongoing |
| Feb 19, 2026 | Efficacy and safety of nnc0487-0111 s.c. once-weekly in participants with overweight or obesity, and knee osteoarthritis (amaze 5)NNC0487-0111 | Novo Nordisk | Ongoing |
| Feb 19, 2026 | Efficacy and safety of nnc0487-0111 s.c. once-weekly in participants with overweight or obesity, and knee osteoarthritis (amaze 6)NNC0487-0111 | Novo Nordisk | Ongoing |
| Sep 12, 2025 | A phase 3 study to investigate the efficacy and safety of orforglipron once daily in participants who have obesity or overweight and osteoarthritis of the…ORFORGLIPRON (LY3502970) | Eli Lilly | Ongoing |
| Aug 29, 2025 | Single dose parallel comparative bioavailability study of triamcinolone hexacetonide following intra-articular administration of a single dose injection of…CINGAL (TRIAMCINOLONE HEXACETONIDE -HYALURONIC ACID) / ARISTOSPAN… | Anika Therapeutics | Ongoing |
| Jul 17, 2025 | Preliminary dosimetry study of homogeneous 117msn hydroxide micriparticles for radiosynoviorthesis in pateints with olsteoarthritis of the kneeHOMOGENOUS 117MSN HYDROXIDE MICROPARTICLES (HTM) | SERENE, LLC | Pending |
| Jul 10, 2025 | A multicenter, randomized, double-blind, placebo-controlled, phase 2 study to evaluate the efficacy and safety of vent-02 in adult participants with painful…VENT-02 | VENTUS THERAPEUTICS U.S | Pending |
| Jun 20, 2025 | Multiprofen-cc to reduce pain in hand arthritis (mrp-hand): a crossover randomized controlled trialAMITRIPTYLINE-BACLOFEN-KETOPROFEN-LIDOCAINE | THE RESEARCH INSITITUTE OF ST. JOSEPH'S HAMILTON | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA